tirzepatide weight loss data vs semaglutide: A new battle in obesity treatment Weight Loss Drugs Part 3

Attenuation of High Glucose-Induced Rat Cardiomyocyte Apoptosis by Exendin-4 via Intervention of HO-1/Nrf-2 and the PI3K/AKT Signaling Pathway

Initially approved by the FDA for adults in June 2021, with approval extended to adolescents aged 12 and older in December 2022, Wegovy belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists

Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US food and drug administration adverse event reporting system

Nutritional deficiencies commonly associated with rapid weight loss can also contribute to hair thinning

Tesofensin Cpsulas Tesofensin is a synthetic small-molecule monoamine reuptake inhibitor investigated for its effects on appetite regulation, energy expenditure, and body composition

doi:10.1186/s12610-019-0090-x Fainberg J, Kashanian JA